Drawing for SIX21

USPTO serial 87701804

SIX21

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
GOODMAN, WENDY BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SIX21?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew Nelson

Andrew Nelson Fortis LLP650 Town Center Drive1530Costa Mesa, CA 92626

Goods and services

ClassDescriptionStatusFirst use
003Hand creams; skin creams; non-medicated salves used for callous protectionACTIVE—
028Toys; toy action figures and accessories; plastic and vinyl character toys and toy animals; toy figures; ride-on toys; plush toys; electronic action toys; mechanical toys; Role playing toys in the nature of play sets consisting of toy animals and accessories therefor; toy guns, cap guns, and accessories; sporting equipment, namely, weightlifting gloves, belts, and wrist wraps; jump ropes; hand grips for gymnasticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 28, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 28, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 26, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 1, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 1, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 27, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 22, 2018ALIEASSIGNED TO LIE—
Mar 15, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 15, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 15, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 15, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 12, 2018DOCKASSIGNED TO EXAMINER—
Dec 11, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 2, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance